AP
MASS icon

Antipodes Partners’s 908 Devices MASS Stock Holding History

Antipodes Partners’s Portfolio MASS Stock Details MASS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Sell
3,994
-408
-9% -$3.13K ﹤0.01% 121
2026
Q1 		$26.9K Sell
4,402
-692
-14% -$4.33K ﹤0.01% 117
2025
Q4 		$26.7K Sell
5,094
-133
-3% -$929 ﹤0.01% 120
2025
Q3 		$45.8K Sell
5,227
-1,331
-20% -$8.84K ﹤0.01% 96
2025
Q2 		$46.8K Buy
6,558
+2,176
+50% +$12.1K ﹤0.01% 88
2025
Q1 		$19.6K Buy
+4,382
New +$13K ﹤0.01% 97

Other funds holding MASS

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Antipodes Partners's MASS Position: Q2 2026 in Review

Antipodes Partners reduced its 908 Devices (MASS) stake by 9.3% in Q2 2026, selling an estimated $3.13K and leaving 3,994 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #121.

Antipodes Partners first reported a position in MASS in Q1 2025 and has held it in 6 quarters since. The position peaked at $46.8K in Q2 2025. 112 funds tracked by Wall St. Rank hold MASS as of Q2 2026.

  • Antipodes Partners held 3,994 shares of 908 Devices worth $34.7K as of Q2 2026.
  • Antipodes Partners sold 408 908 Devices shares in Q2 2026, an estimated $3.13K.
  • 908 Devices made up ﹤0.01% of Antipodes Partners's portfolio in Q2 2026, its #121 holding.
  • Antipodes Partners first reported a position in 908 Devices in Q1 2025 and has held it in 6 quarters since.
  • Antipodes Partners's 908 Devices position peaked at $46.8K in Q2 2025.
  • 112 funds tracked by Wall St. Rank held 908 Devices as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.